Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/10273| Title: | A phase 3 open-label study of elexacaftor/tezacaftor/ivacaftor in children 6 through 11 years of age with cystic fibrosis and at least one F508del allele | Authors: | Zemanick, E.T. Taylor-Cousar, J.L. Davies, J. Gibson, R.L. Mall, M.A. McKone, E.F. McNally, P. Ramsey, B.W. Rayment, J.H. Rowe, S.M. Tullis, E. Ahluwalia, N. Chu, C. Ho, T. Moskowitz, S.M. Noel, S. Tian, S. Waltz, D. Weinstock, T.G. Xuan, F. Wainwright, C.E. McColley, S.A. |
Issue Date: | 2021 | Journal: | American Journal of Respiratory and Critical Care Medicine |
| Appears in Sites: | Publication workflow Queensland Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.